Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients.
Concern regarding the cardiotoxicity of antimalarials has been renewed because of their potential to cause QT/QTc interval prolongation related to torsade de pointes (TdP). Artemisinin-piperaquine (AP) is considered an effective artemisinin-based combination therapy (ACT) for malaria. This study involved a retrospective analysis of clinical data of 93 hospitalized malaria patients who had received AP orally. Electrocardiograms (ECGs) were obtained at specific time points in the original study. Some cases of QT prolongation were observed. However, no TdP was found. AP may cause QT interval prolongation in some malaria patients but may not lead to TdP.